Comment on

• Is technological change in medicine worth it?

  Cutler DM, McClellan M. Cutler DM, et al. Health Aff (Millwood). 2001 Sep-Oct;20(5):11-29. doi: 10.1377/hlthaff.20.5.11. Health Aff (Millwood). 2001. PMID: 11558696
• Perspectives on the pharmaceutical industry.

  Reinhardt UE. Reinhardt UE. Health Aff (Millwood). 2001 Sep-Oct;20(5):136-49. doi: 10.1377/hlthaff.20.5.136. Health Aff (Millwood). 2001. PMID: 11558698
• The link between gross profitability and pharmaceutical R&D spending.

  Scherer FM. Scherer FM. Health Aff (Millwood). 2001 Sep-Oct;20(5):216-20. doi: 10.1377/hlthaff.20.5.216. Health Aff (Millwood). 2001. PMID: 11558706 No abstract available.
• Probing the link between gross profitability and R&D spending.

  Lichtenberg FR. Lichtenberg FR. Health Aff (Millwood). 2001 Sep-Oct;20(5):221-2. doi: 10.1377/hlthaff.20.5.221. Health Aff (Millwood). 2001. PMID: 11558707 No abstract available.
• Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPS.

  Lichtenberg FR. Lichtenberg FR. Health Aff (Millwood). 2001 Sep-Oct;20(5):241-51. doi: 10.1377/hlthaff.20.5.241. Health Aff (Millwood). 2001. PMID: 11558710